vs

Side-by-side financial comparison of International Money Express, Inc. (IMXI) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

International Money Express, Inc. is the larger business by last-quarter revenue ($147.4M vs $127.1M, roughly 1.2× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -10.5%). International Money Express, Inc. produced more free cash flow last quarter ($-20.0M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs -1.0%).

American Express Company or Amex is an American bank holding company and multinational financial services corporation that specializes in payment cards. It is headquartered at 200 Vesey Street, also known as American Express Tower, in the Battery Park City neighborhood of Lower Manhattan.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

IMXI vs ZLAB — Head-to-Head

Bigger by revenue
IMXI
IMXI
1.2× larger
IMXI
$147.4M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+27.6% gap
ZLAB
17.1%
-10.5%
IMXI
More free cash flow
IMXI
IMXI
$6.7M more FCF
IMXI
$-20.0M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
-1.0%
IMXI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMXI
IMXI
ZLAB
ZLAB
Revenue
$147.4M
$127.1M
Net Profit
$8.9M
Gross Margin
51.0%
Operating Margin
7.9%
-54.6%
Net Margin
6.1%
Revenue YoY
-10.5%
17.1%
Net Profit YoY
-41.9%
EPS (diluted)
$0.29
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$147.4M
$127.1M
Q3 25
$154.9M
$115.4M
Q2 25
$161.1M
$109.1M
Q1 25
$144.3M
$105.7M
Q4 24
$164.8M
$108.5M
Q3 24
$171.9M
$101.8M
Q2 24
$171.5M
$100.1M
Q1 24
$150.4M
$87.1M
Net Profit
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$8.9M
Q3 25
$5.0M
$-36.0M
Q2 25
$11.0M
$-40.7M
Q1 25
$7.8M
$-48.4M
Q4 24
$15.4M
Q3 24
$17.3M
$-41.7M
Q2 24
$14.0M
$-80.3M
Q1 24
$12.1M
$-53.5M
Gross Margin
IMXI
IMXI
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
IMXI
IMXI
ZLAB
ZLAB
Q4 25
7.9%
-54.6%
Q3 25
6.8%
-42.3%
Q2 25
12.1%
-50.3%
Q1 25
9.8%
-53.3%
Q4 24
15.0%
-62.6%
Q3 24
16.2%
-66.6%
Q2 24
13.4%
-76.0%
Q1 24
13.0%
-80.7%
Net Margin
IMXI
IMXI
ZLAB
ZLAB
Q4 25
6.1%
Q3 25
3.2%
-31.2%
Q2 25
6.8%
-37.3%
Q1 25
5.4%
-45.8%
Q4 24
9.3%
Q3 24
10.1%
-40.9%
Q2 24
8.2%
-80.2%
Q1 24
8.0%
-61.4%
EPS (diluted)
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$0.29
$-0.05
Q3 25
$0.17
$-0.03
Q2 25
$0.37
$-0.04
Q1 25
$0.25
$-0.04
Q4 24
$0.49
$-0.09
Q3 24
$0.53
$-0.04
Q2 24
$0.42
$-0.08
Q1 24
$0.35
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMXI
IMXI
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$168.7M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$161.1M
$715.5M
Total Assets
$517.7M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$168.7M
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$757.3M
Q4 24
$130.5M
$779.7M
Q3 24
$616.1M
Q2 24
$630.0M
Q1 24
$650.8M
Stockholders' Equity
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$161.1M
$715.5M
Q3 25
$149.7M
$759.9M
Q2 25
$142.3M
$791.7M
Q1 25
$139.2M
$810.8M
Q4 24
$134.9M
$840.9M
Q3 24
$141.8M
$667.7M
Q2 24
$142.4M
$704.2M
Q1 24
$138.2M
$762.2M
Total Assets
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$517.7M
$1.2B
Q3 25
$478.7M
$1.2B
Q2 25
$518.0M
$1.2B
Q1 25
$490.6M
$1.2B
Q4 24
$462.4M
$1.2B
Q3 24
$480.9M
$985.3M
Q2 24
$612.4M
$987.4M
Q1 24
$548.7M
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMXI
IMXI
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-15.6M
$-26.0M
Free Cash FlowOCF − Capex
$-20.0M
$-26.7M
FCF MarginFCF / Revenue
-13.6%
-21.0%
Capex IntensityCapex / Revenue
3.0%
0.5%
Cash ConversionOCF / Net Profit
-1.75×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$-15.6M
$-26.0M
Q3 25
$-28.7M
$-32.0M
Q2 25
$39.9M
$-31.0M
Q1 25
$41.3M
$-61.7M
Q4 24
$-4.9M
$-55.8M
Q3 24
$29.3M
$-26.8M
Q2 24
$-19.6M
$-42.2M
Q1 24
$48.2M
$-90.1M
Free Cash Flow
IMXI
IMXI
ZLAB
ZLAB
Q4 25
$-20.0M
$-26.7M
Q3 25
$-35.5M
$-35.0M
Q2 25
$35.3M
$-33.9M
Q1 25
$36.0M
$-63.2M
Q4 24
$-8.8M
$-58.4M
Q3 24
$23.4M
$-28.2M
Q2 24
$-26.2M
$-42.9M
Q1 24
$34.8M
$-91.1M
FCF Margin
IMXI
IMXI
ZLAB
ZLAB
Q4 25
-13.6%
-21.0%
Q3 25
-22.9%
-30.4%
Q2 25
21.9%
-31.1%
Q1 25
25.0%
-59.9%
Q4 24
-5.4%
-53.8%
Q3 24
13.6%
-27.7%
Q2 24
-15.3%
-42.9%
Q1 24
23.1%
-104.5%
Capex Intensity
IMXI
IMXI
ZLAB
ZLAB
Q4 25
3.0%
0.5%
Q3 25
4.4%
2.6%
Q2 25
2.8%
2.6%
Q1 25
3.7%
1.5%
Q4 24
2.4%
2.4%
Q3 24
3.4%
1.3%
Q2 24
3.9%
0.7%
Q1 24
9.0%
1.1%
Cash Conversion
IMXI
IMXI
ZLAB
ZLAB
Q4 25
-1.75×
Q3 25
-5.78×
Q2 25
3.63×
Q1 25
5.31×
Q4 24
-0.32×
Q3 24
1.69×
Q2 24
-1.39×
Q1 24
3.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMXI
IMXI

Wire Transfer And Money Order$121.2M82%
Other$21.0M14%
Financial Service Other$5.2M4%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons